Dr. Patrick Soon-Shiong, M.D., a physician, surgeon, scientist, inventor, technologist and philanthropist, has devoted his career to understanding the fundamental biology driving life-threatening diseases and translating these insights into medical innovations with global impact. He serves as Chairman and Chief Executive Officer of NantWorks, an ecosystem of companies with deep understandings in a wide variety of complex industries, from medical science to physics, from data to AI and from communications to mobility.
Over the course of Dr. Soon-Shiong’s career, he has pioneered novel therapies for both diabetes and cancer, including the revolutionary drug Abraxane, a protein nanoparticle, which has received U.S. Food and Drug Administration (FDA) approval for the treatment of metastatic breast cancer, lung cancer and advanced pancreatic cancer in both the U.S. and E.U., published more than 100 scientific papers, and has been granted more than 400 patents worldwide for groundbreaking advancements spanning myriad fields of technology and medicine.
In 2020, Dr. Soon-Shiong and his scientific team devoted their resources and scientific expertise to the development of a vaccine to address the COVID-19 pandemic. Utilizing their expertise in treating cancer, Dr. Soon-Shiong and his team took the novel approach of developing a vaccine that would induce both antibodies and T cells to clear the virus.
Dr. Soon-Shiong is also the owner and Executive Chairman of California Times, publisher of two of the state’s largest newspapers, the Los Angeles Times and The San Diego Union-Tribune.
